6BI0
Trastuzumab Fab N158A, D185A, K190A (Light Chain) Triple Mutant.
6BI0 の概要
| エントリーDOI | 10.2210/pdb6bi0/pdb |
| 関連するPDBエントリー | 6BHZ |
| 分子名称 | Trastuzumab anti-HER2 Fab Heavy Chain, Trastuzumab anti-HER2 Fab Light Chain, 1,2-ETHANEDIOL, ... (4 entities in total) |
| 機能のキーワード | fab, immunoglobulin, mutant, immune system |
| 由来する生物種 | Homo sapiens 詳細 |
| タンパク質・核酸の鎖数 | 4 |
| 化学式量合計 | 94991.90 |
| 構造登録者 | |
| 主引用文献 | Pham, G.H.,Ou, W.,Bursulaya, B.,DiDonato, M.,Herath, A.,Jin, Y.,Hao, X.,Loren, J.,Spraggon, G.,Brock, A.,Uno, T.,Geierstanger, B.H.,Cellitti, S.E. Tuning a Protein-Labeling Reaction to Achieve Highly Site Selective Lysine Conjugation. Chembiochem, 19:799-804, 2018 Cited by PubMed Abstract: Activated esters are widely used to label proteins at lysine side chains and N termini. These reagents are useful for labeling virtually any protein, but robust reactivity toward primary amines generally precludes site-selective modification. In a unique case, fluorophenyl esters are shown to preferentially label human kappa antibodies at a single lysine (Lys188) within the light-chain constant domain. Neighboring residues His189 and Asp151 contribute to the accelerated rate of labeling at Lys188 relative to the ≈40 other lysine sites. Enriched Lys188 labeling can be enhanced from 50-70 % to >95 % by any of these approaches: lowering reaction temperature, applying flow chemistry, or mutagenesis of specific residues in the surrounding protein environment. Our results demonstrated that activated esters with fluoro-substituted aromatic leaving groups, including a fluoronaphthyl ester, can be generally useful reagents for site-selective lysine labeling of antibodies and other immunoglobulin-type proteins. PubMed: 29388367DOI: 10.1002/cbic.201700611 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.057 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






